Medical device firm Withings has received US FDA clearance to release its BPM Pro 2 cellular blood pressure monitor. The device allows users to answer contextual questions set by doctors to improve medication compliance, collected along with symptom information to provide a more comprehensive picture of the patient’s health. The monitor can detect anomalies and send follow-up reminders, as well as reminding users to schedule doctors’ appointments.
Kowloon East Cluster April 05: 56k Patient Data Leak Spurs Cyber Spend – Meyka
Kowloon East Cluster April 05: 56k Patient Data Leak Spurs Cyber Spend Meyka
